Lee Rubin, Principal Investigator and Director of Translational Medicine at Harvard Stem Cell Institute, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âUsing stem cell-based screens to model neurodegenerative disorders.'
In the presentation, Lee gives an overview on:
- Using stem cell-based screens to study the biology of orphan nervous system disorders and identify therapeutic targets
- How to address diseases without a strong genetic component
- How to address genetic variability
- Implications for the pharmaceutical industry: how does iPS disease modeling hold the potential to drastically improve drug pipelines for neurodegenerative diseases?
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.
Brock Reeve, Executive Director at the Harvard Stem Cell Institute, will be participating in a panel session at this year's conference on the topic, âLooking to alternative funding sources for the RM field.'